NASDAQ: XFORX4 Pharmaceuticals Inc Stock Ownership - Who owns X4 Pharmaceuticals?
Insider buying vs selling
Have X4 Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adam S. Mostafa | Chief Financial Officer | 2024-03-11 | 52,500 | $0.88 | $46.36kSell |
| Arthur Taveras | Chief Scientific Officer | 2024-03-11 | 14,235 | $0.88 | $12.56kSell |
| Paula Ragan | President and CEO | 2024-03-11 | 49,678 | $0.88 | $43.87kSell |
| Mary Dibiase | Chief Operating Officer | 2024-03-11 | 15,409 | $0.88 | $13.59kSell |
| Paula Ragan | President and CEO | 2024-02-12 | 21,695 | $1.01 | $21.89kSell |
| Adam S. Mostafa | Chief Financial Officer | 2024-02-12 | 27,721 | $1.01 | $27.97kSell |
| Arthur Taveras | Chief Scientific Officer | 2024-02-12 | 787 | $1.01 | $792.51Sell |
| Mary Dibiase | Chief Operating Officer | 2024-02-12 | 3,683 | $1.01 | $3.71kSell |
| Paula Ragan | President and CEO | 2023-11-03 | 39,906 | $0.90 | $35.92kSell |
| Mark Baldry | Chief Commercial Officer | 2023-11-01 | 10,257 | $0.73 | $7.49kSell |
XFOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XFOR insiders and whales buy or sell their stock.
XFOR Shareholders
What type of owners hold X4 Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors LLC | 10.07% | 16,915,784 | $18.44M | Institution |
| Nea Management Company LLC | 8.92% | 14,986,793 | $16.34M | Institution |
| Blackrock Inc | 5.01% | 8,417,524 | $9.18M | Institution |
| Vanguard Group Inc | 4.77% | 8,008,865 | $8.73M | Institution |
| Orbimed Advisors LLC | 4.25% | 7,133,515 | $7.78M | Institution |
| Adage Capital Partners GP LLC | 2.55% | 4,276,315 | $4.66M | Institution |
| Sio Capital Management LLC | 2.14% | 3,588,427 | $3.91M | Institution |
| Perceptive Advisors LLC | 2.11% | 3,545,454 | $3.86M | Institution |
| Kingdon Capital Management LLC | 2.07% | 3,473,683 | $3.79M | Institution |
| Axa Sa | 1.83% | 3,073,532 | $3.35M | Institution |
XFOR vs Biotech Stocks
X4 Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.